Product/Composition:- | Doxycycline tablets and capsules |
---|---|
Strength:- | 100 mg, 50 mg |
Form:- | Oral Tablets and Capsules |
Reference Brands:- | Vibramycin(EU & US) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Doxycycline inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, preventing aminoacyl-tRNA attachment. It effectively treats respiratory, urinary, and skin infections. Benefits include broad-spectrum activity, good oral absorption, and anti-inflammatory properties, making it useful for acne, tick-borne diseases, and other bacterial infections.
Doxycycline tablets and capsules are approved in the EU and US for treating respiratory, urinary, skin, and tick-borne infections. In the EU, brands like Vibramycin and generics are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical data, with generic options widely available. Both regions require detailed dossiers, including clinical trial results, manufacturing practices, and pharmacovigilance plans, for approval and ongoing safety monitoring. For regulatory dossier assistance, compliance, and registration, visit PharmaTradz. We support seamless market access for doxycycline formulations, ensuring adherence to European and US standards for safe, effective antibacterial therapy.